Split Fed. Circ. Revives Sequenom Fetal DNA Test Patents
A divided Federal Circuit panel on Tuesday revived claims of two Sequenom Inc. patents licensed by Illumina Inc., saying that unlike other fetal DNA testing patents previously challenged by Ariosa Diagnostics,...To view the full article, register now.
Already a subscriber? Click here to view full article